Chemicals and Drugs

Ad26COVS1

A viral vector vaccine designed against SARS-CoV-2 developed by Johnson & Johnson. Its vector encodes the SARS-CoV-2 Spike protein.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

A viral vector vaccine designed against SARS-CoV-2 developed by Johnson & Johnson. Its vector encodes the SARS-CoV-2 Spike protein.

MeSH Record

Classification

Broader headings

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

MeSH Record

Synonyms

8 entry terms
  • Ad26.COV2.S
  • COVID-19 Vaccine Johnson & Johnson
  • Johnson & Johnson Covid-19 Vaccine
  • COVID 19 Vaccine Johnson & Johnson
  • Johnson & Johnson Covid 19 Vaccine
  • JNJ 78436735
  • JNJ-78436735
  • JNJ78436735

MeSH Record

Aspects Covered

27 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.

MeSH Record

History Note

2022

MeSH Hierarchy

Tree Number

  1. D20.215.894w.899.085w.125w

AMA Style

References

  1. National Library of Medicine. Ad26COVS1. Medical Subject Headings (MeSH). 2026. Unique ID D000090984. http://id.nlm.nih.gov/mesh/2026/D000090984
  2. Ad26COVS1. In: Wikipedia. https://en.wikipedia.org/wiki/Janssen_COVID-19_vaccine
  3. Ad26COVS1. In: Wikidata. https://www.wikidata.org/wiki/Q98655215